Human Antibody Responses to VlsE Antigenic Variation Protein ofBorrelia burgdorferi

Abstract

ABSTRACTVlsE is a 35-kDa surface-exposed lipoprotein ofBorrelia burgdorferithat was shown previously to undergo antigenic variation through segmental recombination of silentvlscassettes withvlsEduring experimental mouse infections. Previous data had indicated that sera from North American Lyme disease patients and experimentally infected animals contained antibodies reactive with VlsE. In this study, sera from patients with Lyme disease, syphilis, and autoimmune conditions as well as from healthy controls were examined for reactivity with VlsE by Western blotting and enzyme-linked immunosorbent assay (ELISA). Strong Western blot reactivity to a recombinant VlsE cassette region protein was obtained consistently with Lyme disease sera. Although sera from Lyme disease patients also reacted with a band corresponding to VlsE inB. burgdorferiB31-5A3, interpretation was complicated by low levels of VlsE expression in in vitro-culturedB. burgdorferiand by the presence of comigrating bands. An ELISA using recombinant VlsE was compared with an ELISA using sonically disruptedB. burgdorferias the antigen. For a total of 93 Lyme disease patient sera examined, the VlsE ELISA yielded sensitivities of 63% for culture-confirmed erythema migrans cases and 92% for later stages, as compared to 61 and 98%, respectively, for the “whole-cell” ELISA. The specificities of the two assays with healthy blood donor sera were comparable, but the VlsE ELISA was 90% specific with sera from syphilis patients, compared to 20% specificity for the whole-cell ELISA with this group. Neither assay showed reactivity with a panel of sera from 20 non-Lyme disease arthritis patients or 20 systemic lupus erythematosus patients. Our results indicate that VlsE may be useful in the immunodiagnosis of Lyme disease and may offer greater specificity than ELISAs using wholeB. burgdorferias the antigen.

Key Biomarkers

Symptom Clusters